PTGS2 and neoplasm: These include inhibition of tumor growth and proliferation, induction of apoptosis in cancer cells, downregulation of the nuclear factor kappa b (NF-κB) pathway, cytokine regulation, upregulation of MAP kinase phosphatase 5 (MKP5), and inhibition of cyclooxygenase 2 (COX-2) (224–227).